Articles

Popular News

Interviews May 8, 2026

Challenges in Technology Transfer for Oligonucleotide Therapeutics: Analytical Complexity, Process Robustness, and CMC Readiness with Rowshon Alam, Ph.D. — Vice President, Prime Medicine, Inc.

A strategic deep dive with Rowshon Alam, Ph.D. of Prime Medicine on analytical complexity, process robustness, and technology transfer readiness in next-generation oligonucleotide therapeutics.

Interviews April 28, 2026

The Future of RNA CMC: Early Strategy, Smart Outsourcing, and Fully Integrated Development Architectures with Hagen Cramer, Ph.D., QurAlis CTO

Breaking CMC bottlenecks in RNA therapeutics is no longer a technical challenge, it is a strategic imperative under Hagen Cramer’s biotech leadership at QurAlis.

Interviews April 23, 2026

De-Risking Biotech Investment Through CMC: Aligning Process Development, Manufacturing, and Market Viability with Seshu Tummala, PhD

From scaling gene-editing pipelines at CRISPR Therapeutics to leading end-to-end drug substance manufacturing at Uniquity Bio, Dr. Seshu Tummala defines how CMC strategy transforms breakthrough science into scalable, real-world therapeutics.

Immunology & Oncology April 9, 2026

Upcoming

San Diego – West Coast USA

Medicinal Chemistry and Drug Discovery Biology Strategy Meeting West Coast USA 2026

13th of May, 2026

Learn more

Clinical Operations & Clinical Trial Supply Chain Strategy Meeting West Coast 2026

14th of May, 2026

Learn more

Boston – East Coast USA

Medicinal Chemistry Strategy Meeting East Coast USA 2026

18th of May, 2026

Learn more

Chemistry Manufacturing and Controls Strategy Meeting East Coast USA 2026

19th of May, 2026

Learn more

Inside Johnson & Johnson’s External Innovation Engine: Devin Swanson on Translating Integrated Discovery into Strategic Value

From Data to Decision: Shicheng Guo’s Systems Approach to AI-Enabled Drug Development

Digital Stewardship: Governing Access, Transparency, and Accountability in Clinical Data Warehouses

Popular News

Challenges in Technology Transfer for Oligonucleotide Therapeutics: Analytical Complexity, Process Robustness, and CMC Readiness with Rowshon Alam, Ph.D. — Vice President, Prime Medicine, Inc.

The Future of RNA CMC: Early Strategy, Smart Outsourcing, and Fully Integrated Development Architectures with Hagen Cramer, Ph.D., QurAlis CTO

De-Risking Biotech Investment Through CMC: Aligning Process Development, Manufacturing, and Market Viability with Seshu Tummala, PhD

From DMPK to Distributed Execution: Mehran F. Moghaddam’s Systems Strategy at OROX BioSciences, Inc.

Oncology Rewired: Molecularly Precise Therapeutics Redefining the Architecture of Cancer Treatment

Degradation Code: Rewriting Pathology by Reprogramming Intracellular Protein Fate

Zentalis Pharmaceuticals’ Clinical Strategy Architecture: Dr. Stalder on Data Foresight and Oncology Execution

Signal Switch: Stimuli-Responsive Nanoplatforms That Turn STING On Only Where Tumors Make Sense

Marrow Whispers: How B-Cell Circuitry May Shape Acquired Aplastic Anemia and Why CD20 Depletion Is Being Reconsidered

Epigenetic Command: SETD Enzymes Rewire Immune Transcription in Inflammatory Disease

Cytokine Brakes: Why Targeting p38 Can Tame Endotoxin-Driven Inflammation

When Signals Fail: IL-2 Receptor Alpha Chain Defects and the Hidden Architecture of Immune Tolerance

Upcoming

San Diego – West Coast USA

Medicinal Chemistry and Drug Discovery Biology Strategy Meeting West Coast USA 2026

Clinical Operations & Clinical Trial Supply Chain Strategy Meeting West Coast 2026

Boston – East Coast USA

Medicinal Chemistry Strategy Meeting East Coast USA 2026

Chemistry Manufacturing and Controls Strategy Meeting East Coast USA 2026

Inside Johnson & Johnson’s External Innovation Engine: Devin Swanson on Translating Integrated Discovery into Strategic Value

From Data to Decision: Shicheng Guo’s Systems Approach to AI-Enabled Drug Development

Digital Stewardship: Governing Access, Transparency, and Accountability in Clinical Data Warehouses

Articles

Popular News

Challenges in Technology Transfer for Oligonucleotide Therapeutics: Analytical Complexity, Process Robustness, and CMC Readiness with Rowshon Alam, Ph.D. — Vice President, Prime Medicine, Inc.

The Future of RNA CMC: Early Strategy, Smart Outsourcing, and Fully Integrated Development Architectures with Hagen Cramer, Ph.D., QurAlis CTO

De-Risking Biotech Investment Through CMC: Aligning Process Development, Manufacturing, and Market Viability with Seshu Tummala, PhD

From DMPK to Distributed Execution: Mehran F. Moghaddam’s Systems Strategy at OROX BioSciences, Inc.

Oncology Rewired: Molecularly Precise Therapeutics Redefining the Architecture of Cancer Treatment

Degradation Code: Rewriting Pathology by Reprogramming Intracellular Protein Fate

Zentalis Pharmaceuticals’ Clinical Strategy Architecture: Dr. Stalder on Data Foresight and Oncology Execution

Signal Switch: Stimuli-Responsive Nanoplatforms That Turn STING On Only Where Tumors Make Sense

Marrow Whispers: How B-Cell Circuitry May Shape Acquired Aplastic Anemia and Why CD20 Depletion Is Being Reconsidered

Epigenetic Command: SETD Enzymes Rewire Immune Transcription in Inflammatory Disease

Cytokine Brakes: Why Targeting p38 Can Tame Endotoxin-Driven Inflammation

When Signals Fail: IL-2 Receptor Alpha Chain Defects and the Hidden Architecture of Immune Tolerance

Subscribe to get our LATEST NEWS

Upcoming

San Diego – West Coast USA

Medicinal Chemistry and Drug Discovery Biology Strategy Meeting West Coast USA 2026

Clinical Operations & Clinical Trial Supply Chain Strategy Meeting West Coast 2026

Boston – East Coast USA

Medicinal Chemistry Strategy Meeting East Coast USA 2026

Chemistry Manufacturing and Controls Strategy Meeting East Coast USA 2026

Subscribe
to get our
LATEST NEWS